CDXS Codexis Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: CDXS

Price (delayed)

$2.83

Market cap

$198.96M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.12

Enterprise value

$148.29M

Highlights
The debt has plunged by 63% YoY and by 20% from the previous quarter
CDXS's gross margin is up by 13% year-on-year and by 9% since the previous quarter
The company's net income has shrunk by 127% YoY but it rose by 7% QoQ
The EPS has dropped by 120% year-on-year but it is up by 7% since the previous quarter
CDXS's revenue is down by 49% year-on-year and by 5% since the previous quarter
The equity has declined by 40% year-on-year and by 5% since the previous quarter
Sector: Healthcare
Industry: Biotechnology
Website: https://www.cedexis.com/
Peers: BCPC MRK PFE DD

Key stats

What are the main financial stats of CDXS
Market
Shares outstanding
70.3M
Market cap
$198.96M
Enterprise value
$148.29M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.28
Price to sales (P/S)
2.75
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.11
Earnings
Revenue
$70.14M
EBIT
-$76.17M
EBITDA
-$66.25M
Free cash flow
-$56.31M
Per share
EPS
-$1.12
Free cash flow per share
-$0.83
Book value per share
$1.24
Revenue per share
$1.03
TBVPS
$1.97
Balance sheet
Total assets
$136.56M
Total liabilities
$49.95M
Debt
$16.02M
Equity
$86.62M
Working capital
$57.64M
Liquidity
Debt to equity
0.19
Current ratio
2.61
Quick ratio
2.39
Net debt/EBITDA
0.76
Margins
EBITDA margin
-94.4%
Gross margin
81.7%
Net margin
-108.7%
Operating margin
-97%
Efficiency
Return on assets
-42.6%
Return on equity
-71.2%
Return on invested capital
-91.5%
Return on capital employed
-75.6%
Return on sales
-108.6%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

CDXS stock price

How has the Codexis stock price performed over time
Intraday
1.07%
1 week
-1.39%
1 month
-13.46%
1 year
-33.25%
YTD
-7.21%
QTD
-18.91%

Financial performance

How have Codexis's revenue and profit performed over time
Revenue
$70.14M
Gross profit
$57.33M
Operating income
-$68.07M
Net income
-$76.24M
Gross margin
81.7%
Net margin
-108.7%
The company's net income has shrunk by 127% YoY but it rose by 7% QoQ
The company's operating income has shrunk by 95% YoY but it rose by 17% QoQ
CDXS's revenue is down by 49% year-on-year and by 5% since the previous quarter
Codexis's gross profit has decreased by 43% YoY but it has increased by 3.2% QoQ

Growth

What is Codexis's growth rate over time

Valuation

What is Codexis stock price valuation
P/E
N/A
P/B
2.28
P/S
2.75
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.11
The EPS has dropped by 120% year-on-year but it is up by 7% since the previous quarter
CDXS's price to book (P/B) is 64% lower than its 5-year quarterly average of 6.3 but 20% higher than its last 4 quarters average of 1.9
The equity has declined by 40% year-on-year and by 5% since the previous quarter
The price to sales (P/S) is 73% lower than the 5-year quarterly average of 10.1 but 20% higher than the last 4 quarters average of 2.3
CDXS's revenue is down by 49% year-on-year and by 5% since the previous quarter

Efficiency

How efficient is Codexis business performance
The company's return on invested capital fell by 16% QoQ
Codexis's return on assets has decreased by 8% QoQ
Codexis's return on equity has decreased by 6% QoQ

Dividends

What is CDXS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CDXS.

Financial health

How did Codexis financials performed over time
CDXS's total assets is 173% greater than its total liabilities
The total liabilities has dropped by 53% year-on-year and by 21% since the previous quarter
CDXS's total assets is down by 45% year-on-year and by 12% since the previous quarter
The debt is 81% less than the equity
The debt has plunged by 63% YoY and by 20% from the previous quarter
The equity has declined by 40% year-on-year and by 5% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.